Sherlock Biosciences launches with $35 mln capital
Sherlock Biosciences said March 21 that it has launched with $35 million in committed capital. This includes a $17.5 million non-dilutive grant and an investment from the Open Philanthropy Project. Sherlock, of Cambridge, Massachusetts, is an engineering biology company that seeks to make testing better, faster and more affordable.
21 March 2019•6 mins read
